Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 13 filers reported holding Astellas Pharma Inc in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| THOMAS WHITE INTERNATIONAL LTD | 339,011 | $5,024,000 | 0.72% |
| GRATRY & Co LLC | 83,750 | $1,243,000 | 0.41% |
| GlobalBridge, Inc. | 14,392 | $213,000 | 0.11% |
| Aperio Group, LLC | 454,127 | $6,729,000 | 0.10% |
| ZEVIN ASSET MANAGEMENT LLC | 18,581 | $276,000 | 0.08% |
| ETRADE Capital Management LLC | 63,601 | $942,000 | 0.07% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 411,463 | $6,106,000 | 0.02% |
| PRIVATE TRUST CO NA | 456 | $7,000 | 0.00% |
| First Horizon Advisors, Inc. | 290 | $4,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 10,929 | $163,000 | 0.00% |